Bcr-Abl Directly Activates Stat5 Independent of Jak2

被引:0
|
作者
Hantschel, Oliver D. [1 ]
Eckelhart, Eva [2 ]
Kaupe, Ines [1 ]
Grebien, Florian [1 ]
Wagner, Kay-Uwe [3 ]
Sexl, Veronika [4 ,5 ]
Superti-Furga, Giulio [1 ]
机构
[1] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[2] Med Univ Vienna, Ctr Pharmacol & Physiol, Vienna, Austria
[3] Univ Nebraska Med Ctr, Eppley Inst Res Caner & Allied Dis, Omaha, NE USA
[4] Med Univ Vienna, Dept Biomed Sci, Vienna, Austria
[5] Vet Univ Vienna, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:226 / 226
页数:1
相关论文
共 50 条
  • [21] Chronic Myeloproliferative Neoplasm with Concurrent BCR-ABL Trans location and JAK2 Mutation
    Siddiqui, Nauman Saleem
    Ssiddiqui, Haroon Saleem
    Dr Qurat-ul-Ain
    Siddiqui, Saleem Ahmad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (06): : 423 - 423
  • [22] Interleukin 3 activates not only JAK2 and STAT5, but also Tyk2, STAT1, and STAT3
    Nagata, Y
    Todokoro, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) : 785 - 789
  • [23] Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2
    Grebien, Florian
    Kerenyi, Marc A.
    Kovacic, Boris
    Kolbe, Thomas
    Becker, Verena
    Dolznig, Helmut
    Pfeffer, Klaus
    Klingmueller, Ursula
    Mueller, Mathias
    Beug, Hartmut
    Muellner, Ernst W.
    Moriggl, Richard
    BLOOD, 2008, 111 (09) : 4511 - 4522
  • [24] Angiotensin II activates STAT5 through JAK2 kinase in rat kidney mesangial cells.
    Marrero, MB
    Venema, VJ
    Li, B
    Eaton, DC
    Venema, RC
    FASEB JOURNAL, 1999, 13 (04): : A365 - A365
  • [25] Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
    Sarno, Federica
    Pepe, Giacomo
    Termolino, Pasquale
    Carafa, Vincenzo
    Massaro, Crescenzo
    Merciai, Fabrizio
    Campiglia, Pietro
    Nebbioso, Angela
    Altucci, Lucia
    CELLS, 2020, 9 (02)
  • [26] BCR-ABL Affects STAT5A and STAT5B Differentially
    Schaller-Schoenitz, Michael
    Barzan, David
    Williamson, Andrew J. K.
    Griffiths, John R.
    Dallmann, Iris
    Battmer, Karin
    Ganser, Arnold
    Whetton, Anthony D.
    Scherr, Michaela
    Eder, Matthias
    PLOS ONE, 2014, 9 (05):
  • [27] SUPPRESSOR OF CYTOKINE SIGNALING 3 IS DOWN-REGULATED BY BCR-ABL AND RESULTS IN LOSS OF JAK2 V617F IN A PATIENT WITH CONCURRENT BCR-ABL TRANSLOCATION AND JAK2 V617F MUTATION
    Ang, C. H.
    Gan, G. G.
    Nadarajan, V.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 402 - 403
  • [28] Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression
    Kay-Uwe Wagner
    Hallgeir Rui
    Journal of Mammary Gland Biology and Neoplasia, 2008, 13 : 93 - 103
  • [29] Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression
    Wagner, Kay-Uwe
    Rui, Hallgeir
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (01) : 93 - 103
  • [30] JAK2/STAT5 Signaling Pathway Mediates Bojungbangdocktang enhanced Hematopoiesis
    Lim, Jeonghan
    Jeong, Soo-Jin
    Koh, Wonil
    Han, Ihn
    Lee, Hyo-Jung
    Kwon, Tae-Rin
    Jung, Ji Hoon
    Kim, Jung Hyo
    Lee, Hyo-Jeong
    Lee, Eun-Ok
    Kim, Sun-Hyung
    Lee, Min-Ho
    Kim, Sung-Hoon
    PHYTOTHERAPY RESEARCH, 2011, 25 (03) : 329 - 337